These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 9929516)

  • 1. Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1.
    Tang YM; Chen GF; Thompson PA; Lin DX; Lang NP; Kadlubar FF
    Drug Metab Dispos; 1999 Feb; 27(2):274-80. PubMed ID: 9929516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipeptide antibodies against overlapping sequences differentially inhibit human CYP2D6.
    Cribb A; Nuss C; Wang R
    Drug Metab Dispos; 1995 Jul; 23(7):671-5. PubMed ID: 7587952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.
    Laurenzana EM; Sorrels SL; Owens SM
    Drug Metab Dispos; 1995 Feb; 23(2):271-8. PubMed ID: 7736924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1.
    McFadyen MC; Breeman S; Payne S; Stirk C; Miller ID; Melvin WT; Murray GI
    J Histochem Cytochem; 1999 Nov; 47(11):1457-64. PubMed ID: 10544218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
    Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
    Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.
    Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR
    Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monospecific antipeptide antibody to cytochrome P-450 2B6.
    Stresser DM; Kupfer D
    Drug Metab Dispos; 1999 Apr; 27(4):517-25. PubMed ID: 10101147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
    Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T
    Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
    Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
    Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
    Chang TK; Chen J; Lee WB
    J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific expression of cytochrome P450 CYP1B1.
    Murray GI; Taylor MC; McFadyen MC; McKay JA; Greenlee WF; Burke MD; Melvin WT
    Cancer Res; 1997 Jul; 57(14):3026-31. PubMed ID: 9230218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping studies with human anti-cytochrome P450 3A antibodies.
    Leeder JS; Gaedigk A; Lu X; Cook VA
    Mol Pharmacol; 1996 Feb; 49(2):234-43. PubMed ID: 8632755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of a form-specific, inhibitory antibody against rat cytochrome P450 2B1 using a synthetic peptide antigen against a putative substrate binding site.
    Charnecki J; Putt D; Kim EY; Kim H
    Biochem Biophys Res Commun; 1995 Nov; 216(3):1024-33. PubMed ID: 7488175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of methoxyflavonoids on human CYP1B1 activity.
    Takemura H; Itoh T; Yamamoto K; Sakakibara H; Shimoi K
    Bioorg Med Chem; 2010 Sep; 18(17):6310-5. PubMed ID: 20696580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patients.
    Kvistborg P; Hadrup SR; Svane IM; Andersen MH; Straten PT
    Hum Immunol; 2008; 69(4-5):266-72. PubMed ID: 18486761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
    Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
    Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides.
    Boundy VA; Luedtke RR; Artymyshyn RP; Filtz TM; Molinoff PB
    Mol Pharmacol; 1993 May; 43(5):666-76. PubMed ID: 8502224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens.
    Schulz-Utermoehl T; Edwards RJ; Boobis AR
    Drug Metab Dispos; 2000 May; 28(5):544-51. PubMed ID: 10772633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers.
    Kim JH; Sherman ME; Curriero FC; Guengerich FP; Strickland PT; Sutter TR
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):210-9. PubMed ID: 15364538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cytochrome P-450 (CYP) 1B1 in mouse Hepa-1 variant cell lines: A possible role for aryl hydrocarbon receptor nuclear translocator (ARNT) as a suppressor of CYP1B1 gene expression.
    Eltom SE; Zhang L; Jefcoate CR
    Mol Pharmacol; 1999 Mar; 55(3):594-604. PubMed ID: 10051545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.